Levothyroxine therapy and its impact on serum lipids: Addressing dyslipidemia in hypothyroidism

QR Code

Levothyroxine therapy and its impact on serum lipids: Addressing dyslipidemia in hypothyroidism

Background and Objective: The major goal of this study was to analyse the influence of levothyroxine medication on serum lipid levels in individuals with hypothyroidism, as well as its efficacy in controlling dyslipidemia caused by thyroid hormone deficiencies. This method provides a complete assess...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rohit Kumar Gupta, Rajeev Verma, Manisha Verma, Anirudh Mukherjee, Pramod Kumar, Mahendra Kumar Meena, Manu Sharma
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-06-01
Series:	Journal of Family Medicine and Primary Care
Subjects:	dyslipidemia hypothyroidism levothyroxine therapy lipid metabolism serum lipids thyroid hormone replacement
Online Access:	https://journals.lww.com/10.4103/jfmpc.jfmpc_1349_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Subclinical hypothyroidism: treat or watch?
by: I. A. Tsanava, et al.
Published: (2021-03-01)

Predictive factors of permanent versus transient congenital hypothyroidism: a pragmatic cohort study
by: Niki Dermitzaki, et al.
Published: (2025-06-01)

Hypothyroidism: from diagnosis to therapy success. A review
by: Elena V. Biryukova, et al.
Published: (2025-01-01)

The relationship between levothyroxine dosage and free thyroxine levels in hypothyroid patients: a large retrospective study
by: Toshihiko Kasahara
Published: (2025-07-01)

A questionnaire survey of thyroid specialists in Japan on the use of thyroid hormones in hypothyroid and euthyroid patients
by: Yuji Nagayama, et al.
Published: (2025-08-01)

Effect of Hyper and Hypothyroidism on Lipid Profile and Liver Function of Male Rats
by: Baghdad Science Journal
Published: (2011-12-01)

Associations of polyphenolic compounds consumption and the risk of dyslipidemia in the Siberian population
by: T. I. Batluk, et al.
Published: (2020-06-01)

Pathophysiological rationale for the results of atherogenic dyslipidemia simulation in rats
by: V. G. Banzaraksheev
Published: (2016-05-01)

The role of constipation in the development of dyslipidemia in the elderly
by: A. V. Martynenko, et al.
Published: (2025-06-01)

Single-center prospective study on thyroid function outcomes and neurological prognoses at 3 years of age in children with mild neonatal hyperthyrotropinemia
by: Guoyu Sun, et al.
Published: (2025-07-01)

Exploring the link between vitamin D and lipid profile in thyroid disorders: a comparative analysis of hypothyroidism, hyperthyroidism, and healthy control group
by: Awat Hamad Awla, et al.
Published: (2025-01-01)

Levels of serum per- and polyfluoroalkyl substances and association with dyslipidemia in the Korean population
by: Kangyeon Park, et al.
Published: (2025-09-01)

The Pathophysiological Mechanisms and Pattern of Dyslipidemia Associated with Iodine Deficiency and Subclinical Hypothyroidism in Pregnant Normotensive and Preeclamptic Central African Women
by: Charles Bitamazire Businge, et al.
Published: (2025-04-01)

Early postoperative levothyroxine initiation after total thyroidectomy for Graves’ disease
by: Yuji Nagayama, et al.
Published: (2025-07-01)

OPTIMIZATION OF LEVOTHYROXINE THERAPY BASED UPON COMPLEX EVALUATION OF HORMONAL AND IMMUNE STATUS IN THE PATIENTS WITH SUB-CLINICAL AND MANIFESTING HYPOTHYREOSIS
by: I. V. Sarvilina, et al.
Published: (2014-07-01)

Dyslipidemia and Hypertension Among Type 2 Diabetics at a Tertiary Care Hospital of South Gujarat, India
by: Jash Kotak, et al.
Published: (2025-06-01)

Dyslipidemia correction with atorvastatin in patients with coronary heart disease and arterial hypertension
by: N. B. Amirov, et al.
Published: (1970-01-01)

CONTEMPORARY APPROACHES TO LEVOTHYROXINE THERAPY AFTER SURGERY IN PATIENTS WITH WELL-DIFFERENTIATED THYROID CANCER
by: P. O. Rumyantsev, et al.
Published: (2015-04-01)

RELATIONSHIPS BETWEEN LIPID AND IMMUNE DISORDERS AT VARIOUS STAGES OF DEVELOPING EXPERIMENTAL DYSLIPIDEMIA
by: E. G. Lobanova, et al.
Published: (2014-07-01)

Risk Factors Promoting Early Cardiovascular Structure Disorders in Patients with Primary Hypothyroidism
by: A. V. Nikolaeva, et al.
Published: (2022-02-01)

Meta-analysis of the effects of levothyroxine therapy for subclinical hypothyroidism during pregnancy on offspring outcomes
by: Zhiying You, et al.
Published: (2025-07-01)

Evaluation of Role of Prognostic Factors on Hearing Outcome in Unilateral Idiopathic Sudden Onset Sensorineural Hearing Loss
by: Namrata Yadav, et al.
Published: (2023-09-01)

Interchangeability of levothyroxine sodium tablets
by: G. I. Gorodetskaya, et al.
Published: (2018-02-01)

Role of Osteopontin in Hypothyroid Anemic Woman and Their Association with Oxidative Stress
by: Sumesh Prasad Sah, et al.
Published: (2025-04-01)

Lipid profile changes after the acute COVID-19 period. Sub-analysis of the International Registry "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors" (AKTIV SARS-CoV-2)" (12-month follow-up)
by: G. P. Arutyunov, et al.
Published: (2024-04-01)

INFLUENCE OF ENALAPRIL, DIGOXIN, ATENOLOL AND DILTIAZEM ON LIPID PEROXIDATION IN EXPERIMENTAL MODEL OF COMPLEX METABOLIC DISORDERS
by: A. A. Usanova, et al.
Published: (2016-01-01)

Atherogenic dyslipidemia and insulin resistance associated with nonalcohol hepatic steatosis: comparison, contrast, and differentiated therapy
by: L. B. Lazebnik, et al.
Published: (2009-06-01)

Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025)
by: M. V. Ezhov, et al.
Published: (2025-06-01)

Spectrum and Correlates of Dyslipidemia in People Living with HIV on Dolutegravir-Based Regimen Attending Kabutare Hospital, Southern Rwanda: A Cross-Sectional Study
by: Nsengumuremyi H, et al.
Published: (2025-07-01)

Relationship between lipid profile and intraocular pressure in patients of hypertension
by: Chandanveer Singh, et al.
Published: (2025-06-01)

Implemented models and perspectives of managing lipid metabolism disorders. Concept of rare lipid disease centers
by: A. S. Alieva, et al.
Published: (2021-07-01)

Rheumatic manifestations of hypothyroidism
by: L. V. Teplova, et al.
Published: (2017-04-01)

Dyslipidemia in the Russian Federation: population data, associations with risk factors
by: O. M. Drapkina, et al.
Published: (2023-12-01)

LIPID PROFILE PARAMETERS IN THE PERSONS OF YAKUT ETHNICITY WITH METABOLIC SYNDROME COMORBID WITH RESPIRATORY PATHOLOGY
by: E. P. Borisova, et al.
Published: (2015-06-01)

Organization of lipid centers operation in the Russian Federation — new opportunities
by: M. V. Ezhov, et al.
Published: (2021-07-01)

Systematic review: effect of lipid and lipoprotein profiles on atherosclerosis and cardiovascular disease risk in premenopausal and postmenopausal women
by: Avinash Namdeo Jadhao, et al.
Published: (2024-09-01)

Determination of Human Hair Components by Spectrophotometric Methods for the Diagnosis of Thyroid Diseases
by: Fatima H. Salih, et al.
Published: (2024-12-01)

Evaluation of lipid profiles in patients with chronic spontaneous urticaria: A case-control study
by: Abbas Khalili, et al.
Published: (2025-03-01)

Three-year dynamics and unsolved problems of lipid-lowering therapy
by: V. A. Sergeeva
Published: (2015-11-01)

Evaluating the effect of mobile applications “My A:Care” and “Smart Coach” on adherence to lipid-lowering treatment in patients with dyslipidemia: a prospective, randomized, open-label clinical study
by: Chatlert Pongchaiyakul, et al.
Published: (2025-07-01)